Table 2.

miRNAs showing significantly different levels in plasma or serum in HF versus non-HF AMI patients.

Plasma			Serum
miRNA	Fold change	p-value	miRNA	Fold change	p-value
miR-18a-3p	6.193	0.0003	miR-195–5p	6.277	0.0311
miR-30a-5p	4.840	0.0444	miR-378a-3p	5.594	0.0213
miR-99a-5p	3.525	0.0220	miR-30a-5p	5.169	0.0430
miR-99b-5p	2.802	0.0205	miR-22-3p	3.415	0.0003
miR-130a-3p	1.664	0.0261	miR-365a-3p	3.331	0.0296
miR-106a-5p	1.222	0.0385	miR-29c-3p	3.299	0.0263
miR-29a-3p	−1.646	0.0451	miR-30d-5p	3.006	0.0140
let-7g-5p	−1.832	0.0111	miR-99b-5p	2.717	0.0233
miR-29b-3p	−1.854	0.0239	miR-152	2.266	0.0217
miR-142-3p	−1.991	0.0251	let-7d-3p	2.056	0.0014
miR-150-5p	−2.731	0.0104	miR-30e-5p	1.808	0.0018
miR-338-3p	−3.103	0.0454	miR-222-3p	1.783	0.0050
miR-361-3p	−3.951	0.0193	miR-590-5p	1.412	0.0071
miR-146b-5p	−6.311	0.0250	let-7a-5p	−1.507	0.0311
			miR-103a-3p	−1.602	0.0246
			miR-107	−1.604	0.0174

Data are presented as the fold change in the HF group compared to the non-HF group. P-values were calculated using unpaired two-tailed Student’s t-test. Only miRNA species with p < 0.05 are shown. miRNAs common to both types of biological material are indicated in bold.